Will direct-acting antivirals make a difference in HIV-HCV coinfected patients?

被引：0
作者：
Bruno, Raffaele [1 ]
Fagiuoli, Stefano [2 ]
Sacchi, Paolo [1 ]
机构：
[1] Univ Pavia, Dept Infect Dis, Fdn IRCCS Policlin San Matteo, I-27100 Pavia, Italy
[2] Osped Riuniti Bergamo, USC Gastroenterol, I-24100 Bergamo, Italy
来源：
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY | 2011年 / 9卷 / 09期
关键词：
antiretroviral therapy; boceprevir; DAA; DAA-resistance; HIV-HCV coinfection; pharmacokinetic interactions; telaprevir; GENOTYPE; 1; INFECTION; HEPATITIS-C VIRUS; TELAPREVIR; PEGINTERFERON; BOCEPREVIR; RIBAVIRIN;
D O I：
10.1586/ERI.11.85
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
收藏
页码：699 / 701
页数：3
相关论文
共 13 条
  • [1] [Anonymous], 2011, 18 C RETR OPP INF BO
  • [2] [Anonymous], 18 C RETR OPP INF BO
  • [3] Boceprevir for Previously Treated Chronic HCV Genotype 1 Infection
    Bacon, Bruce R.
    Gordon, Stuart C.
    Lawitz, Eric
    Marcellin, Patrick
    Vierling, John M.
    Zeuzem, Stefan
    Poordad, Fred
    Goodman, Zachary D.
    Sings, Heather L.
    Poordad, Fred
    Goodman, Zachary D.
    Sings, Heather L.
    Boparai, Navdeep
    Burroughs, Margaret
    Brass, Clifford A.
    Albrecht, Janice K.
    Esteban, Rafael
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2011, 364 (13) : 1207 - 1217
  • [4] Replication of hepatitis C virus
    Bartenschlager, R
    Lohmann, V
    [J]. JOURNAL OF GENERAL VIROLOGY, 2000, 81 : 1631 - 1648
  • [5] Telaprevir for Previously Untreated Chronic Hepatitis C Virus Infection
    Jacobson, Ira M.
    McHutchison, John G.
    Dusheiko, Geoffrey
    Di Bisceglie, Adrian M.
    Reddy, K. Rajender
    Bzowej, Natalie H.
    Marcellin, Patrick
    Muir, Andrew J.
    Ferenci, Peter
    Flisiak, Robert
    George, Jacob
    Rizzetto, Mario
    Shouval, Daniel
    Sola, Ricard
    Terg, Ruben A.
    Yoshida, Eric M.
    Adda, Nathalie
    Bengtsson, Leif
    Sankoh, Abdul J.
    Kieffer, Tara L.
    George, Shelley
    Kauffman, Robert S.
    Zeuzem, Stefan
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2011, 364 (25) : 2405 - 2416
  • [6] Efficacy of boceprevir, an NS3 protease inhibitor, in combination with peginterferon alfa-2b and ribavirin in treatment-naive patients with genotype 1 hepatitis C infection (SPRINT-1): an open-label, randomised, multicentre phase 2 trial
    Kwo, Paul Y.
    Lawitz, Eric J.
    McCone, Jonathan
    Schiff, Eugene R.
    Vierling, John M.
    Pound, David
    Davis, Mitchell N.
    Galati, Joseph S.
    Gordon, Stuart C.
    Ravendhran, Natarajan
    Rossaro, Lorenzo
    Anderson, Frank H.
    Jacobson, Ira M.
    Rubin, Raymond
    Koury, Kenneth
    Pedicone, Lisa D.
    Brass, Clifford A.
    Chaudhri, Eirum
    Albrecht, Janice K.
    [J]. LANCET, 2010, 376 (9742) : 705 - 716
  • [7] Telaprevir with Peginterferon and Ribavirin for Chronic HCV Genotype 1 Infection
    McHutchison, John G.
    Everson, Gregory T.
    Gordon, Stuart C.
    Jacobson, Ira M.
    Sulkowski, Mark
    Kauffman, Robert
    McNair, Lindsay
    Alam, John
    Muir, Andrew J.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2009, 360 (18) : 1827 - 1838
  • [8] SAFETY AND A ANTIVIRAL ACTIVITY OF A MONOTHERAPY WITH A MP-424 FOR 24 WEEKS IN NAIVE PATIENTS WITH CHRONIC HEPATITIS C VIRUS GENOTYPE 1B INFECTION
    Ozeki, I.
    [J]. JOURNAL OF HEPATOLOGY, 2009, 50 : S350 - S350
  • [9] Boceprevir for Untreated Chronic HCV Genotype 1 Infection
    Poordad, Fred
    McCone, Jonathan, Jr.
    Bacon, Bruce R.
    Bruno, Savino
    Manns, Michael P.
    Sulkowski, Mark S.
    Jacobson, Ira M.
    Reddy, K. Rajender
    Goodman, Zachary D.
    Boparai, Navdeep
    DiNubile, Mark J.
    Sniukiene, Vilma
    Brass, Clifford A.
    Albrecht, Janice K.
    Bronowicki, Jean-Pierre
    Colombato, L.
    Curciarello, J.
    Silva, M.
    Tanno, H.
    Terg, R.
    Adler, M.
    Langlet, P.
    Lasser, L.
    Nevens, F.
    Anderson, F.
    Bailey, R.
    Bilodeau, M.
    Cooper, C.
    Feinman, S. V.
    Heathcote, J.
    Levstik, M.
    Ramji, A.
    Sherman, M.
    Shafran, S.
    Yoshida, E.
    Achim, A.
    Ben Ali, S.
    Bigard, M-A.
    Bonny, C.
    Bourliere, M.
    Boyer-Darrigrand, N.
    Bronowicki, J-P.
    Canva, V.
    Couzigou, P.
    De Ledinghen, V.
    Guyader, D.
    Hezode, C.
    Larrey, D.
    Latournerie, M.
    Marcellin, P.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2011, 364 (13) : 1195 - 1206
  • [10] TELAPREVIR IN COMBINATION WITH PEGINTERFERON ALFA2A AND RIBAVIRIN FOR 24 OR 48 WEEKS IN TREATMENT-NAiVE GENOTYPE 1 HCV PATIENTS WHO ACHIEVED AN EXTENDED RAPID VIRAL RESPONSE: FINAL RESULTS OF PHASE 3 ILLUMINATE STUDY
    Sherman, Kenneth E.
    Flamm, Steven L.
    Afdhal, Nezam H.
    Nelson, David R.
    Sulkowski, Mark S.
    Everson, Gregory T.
    Fried, Michael W.
    Kleber, Kristin
    Martins, Marie
    Sankoh, Abdul J.
    Kauffman, Robert S.
    George, Shelley
    Wright, Christopher I.
    Poordad, Fred
    [J]. HEPATOLOGY, 2010, 52 (04) : 401A - 402A
12